Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02841176Terminated
Open-label, single-arm trial of golimumab in psoriatic arthritis (PsA), sponsored by Imperial College Healthcare NHS Trust. Primary endpoint: Temperature over arthritic joint surface at 97 days. Started Jul 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02841176.